See also this year's filing and all EDGAR filings for this company.
PDF Report 0001401667_2023_PUMA_BIOTECHNOLOGY_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001401667, PUMA BIOTECHNOLOGY INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 134,281,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,146,000 |
| 3 | remainder_Assets | 86,632,000 |
| 4 | LiabilitiesCurrent | 77,484,000 |
| 5 | LiabilitiesNoncurrent | 110,141,000 |
| 6 | remainder_Liabilities | 12,826,000 |
| 7 | CostOfGoodsAndServicesSold | 55,093,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 89,978,000 |
| 9 | ResearchAndDevelopmentExpense | 52,240,000 |
| 10 | remainder_Expenses | 7,455,000 |
| 11 | remainder_Revenues | 228,031,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 2,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 222,059,000 |
| 1 | Liabilities | 200,451,000 |
| 2 | Expenses | 204,766,000 |
| 3 | Revenues | 228,031,000 |
| 4 | StockholdersEquity | 21,608,000 |
| 5 | NetIncome | 23,265,000 |
| 6 | ComprehensiveNetIncome | 23,266,000 |
| 7 | BaseVar | 427,654,500 |
| 8 | EconomicCapitalRatio | 0.286 |